| Abbreviations | Meaning |
 | DS-TRIEL | Decision Support [cancer Clinical] Trial Eligibility |
| TDF | Tumor Dose Fractionation |
| HBC | Hereditary Breast Cancer |
| RLV | Rauscher Leukemia Virus |
| SPT | Second Primary Tumor |
| CAS | Cancer Attitude Survey |
| NCTC | National Cancer Tissue Culture; National Collection Of Type Cultures [UK] |
| EIC | Elastase Inhibition Capacity; Enzyme Inhibition Complex; Extensive Intraductal Carcinoma; Extensive Intraductal Component |
| TSTA | Tumor-specific Tissue Antigen |
| JGCT | Juvenile Granulosa Cell Tumor; Juxtaglomerular Cell Tumor |
| DCP | Des-g-carboxy Prothrombin, Specific For HCC (hepatocellular Carcinoma) |
| ECA | Esophageal Carcinoma |
| IPA | Infiltrating Pancreatic Ductal Adenocarcinoma |
| HAL | Hypocellular Acute Leukemia |
| CPP | Cancer Proneness Phenotype; Canine Pancreatic Polypeptide; Cerebral Perfusion Pressure; Chest Pain Policy; Dl-2[3-(2 |
Browse by Letter:
